Hippo/Yap
<p>miR-520b Promotes Breast Cancer Stemness Through Hippo/YAP Signaling Pathway</p>
10
WWC3 inhibits epithelial–mesenchymal transition of lung cancer by activating Hippo-YAP signaling
11
MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma
14
PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway
12
MiR-591 functions as tumor suppressor in breast cancer by targeting TCF4 and inhibits Hippo-YAP/TAZ signaling pathway
9
Original Article Hippo-YAP signaling pathway is associated with the prognosis in children with osteosarcoma
8
Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression
15
Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance
8
Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer
16
<p>Role of Hippo/YAP signaling in irradiation-induced glioma cell apoptosis</p>
9
Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells
12
S100A7 induction is repressed by YAP via the Hippo pathway in A431 cells
10
Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma
9
Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP
14
The Hippo component YAP localizes in the nucleus of human papilloma virus positive oropharyngeal squamous cell carcinoma
7
Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy
8
Original Article MST1 inhibits cell proliferation and invasion of non-small-cell lung cancer by regulating YAP phosphorylation and Hippo pathway
8
Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer
17
The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer
11
The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease
13